ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,540Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 1844

$982K Total Retail Price of All Prescriptions

Rank: 49 out of 1844

472 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 472 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 472 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 13,957 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
WARFARIN SODIUM 649 581 1 13
LEVOTHYROXINE SODIUM 641 563 2 1
OMEPRAZOLE 518 438 3 5
FUROSEMIDE 515 449 4 7
HYDROCODONE-ACETAMINOPHEN 449 286 S3 5 2
LISINOPRIL 399 367 6 4
SIMVASTATIN 341 273 7 3
TRAMADOL HCL 315 258 8 18
DONEPEZIL HCL 296 292 9 26
CITALOPRAM HBR 293 262 10 19
ESCITALOPRAM OXALATE 267 238 11 52
METOPROLOL TARTRATE 262 231 12 11
JANTOVEN 232 232 13 199
NAMENDA 230 221 14 33
POLYETHYLENE GLYCOL 3350 225 208 15 39
MIRTAZAPINE 215 193 16 49
AMLODIPINE BESYLATE 210 175 17 6
PRAVASTATIN SODIUM 208 169 18 10
CARVEDILOL 207 185 19 22
RISPERIDONE 198 182 20 65
KLOR-CON M20 189 173 21 54
CLOZAPINE 169 136 22 186
CYMBALTA 169 133 22 36
RANITIDINE HCL 168 126 24 38
HYDROCHLOROTHIAZIDE 164 164 25 9
CLOPIDOGREL 154 125 26 34
METFORMIN HCL 152 138 27 8
POTASSIUM CHLORIDE 140 105 28 16
LANTUS 136 109 29 42
GABAPENTIN 134 102 30 15
ALBUTEROL SULFATE 134 89 30 115
ALLOPURINOL 132 107 32 29
FAMOTIDINE 127 80 33 63
NOVOLOG 126 123 34 84
PREDNISONE 121 75 35 40
SPIRONOLACTONE 114 109 36 60
SERTRALINE HCL 111 68 37 21
TAMSULOSIN HCL 110 110 38 27
ATENOLOL 103 84 39 17
FENTANYL 101 89 S2 40 66
DIVALPROEX SODIUM 99 85 41 74
PANTOPRAZOLE SODIUM 98 72 42 32
ATORVASTATIN CALCIUM 97 83 43 12
NYSTATIN 93 55 44 85
IPRATROPIUM-ALBUTEROL 93 70 44 113
MORPHINE SULFATE 92 15 S2 46 207
LEVOFLOXACIN 91 75 47 78
ALENDRONATE SODIUM 90 79 48 25
PLAVIX 89 73 49 61
CARBIDOPA-LEVODOPA 89 86 49 86
HYDROMORPHONE HCL 88 47 S2 51 269
METOPROLOL SUCCINATE 88 64 51 14
NEXIUM 88 60 51 31
FAZACLO 87 36 54 281
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 72 55 73
KLOR-CON M10 85 68 56 149
FINASTERIDE 84 72 57 137
CRESTOR 82 66 58 30
DILTIAZEM HCL 81 63 59 221
TRAZODONE HCL 79 56 60 43
DIGOXIN 77 76 61 67
IPRATROPIUM BROMIDE 75 42 62 198
JANUVIA 73 59 63 77
SPIRIVA 72 72 64 57
ZOLPIDEM TARTRATE 72 38 64 23
CELEBREX 71 59 66 91
LOSARTAN POTASSIUM 71 59 66 24
ISOSORBIDE MONONITRATE ER 70 70 68 59
TRIAMCINOLONE ACETONIDE 70 64 68 153
LOVASTATIN 69 64 70 44
DIOVAN HCT 66 49 71 96
BACLOFEN 66 33 71 119
TORSEMIDE 66 62 71 118
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 60 71 20
LYRICA 64 34 75 92
ROPINIROLE HCL 62 61 76 76
DIOVAN 60 60 77 58
CLONIDINE HCL 60 38 77 64
LEXAPRO 59 53 79 179
COMBIVENT 59 23 79 131
PROMETHAZINE HCL 56 29 R 81 88
PAROXETINE HCL 56 42 81 68
MORPHINE SULFATE ER 56 0 S2 81 107
AMITRIPTYLINE HCL 56 34 R 81 72
GLIPIZIDE 56 56 81 70
BUDESONIDE 54 51 86 330
CYCLOBENZAPRINE HCL 54 32 R 86 53
ALPRAZOLAM 53 0 88 124
NYSTOP 51 46 89 185
OLANZAPINE 51 43 89 117
TRICOR 51 39 89 109
CEPHALEXIN 50 46 92 56
NOVOLOG FLEXPEN 50 47 92 163
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.